DECN may thrive on a 20-30% margin. They don't have to pay

New Post Public Reply Private Reply Replies (0) Message Board
biotech7 weaver_525 #6931
417
DECN may thrive on a 20-30% margin. They don't have to pay 25 director's, country clubs and bribes kick backs and all kinds of creative marketing. Has this worked so far. It is extremely difficult to penetrate a market that is mature. Biotechs that have raised hundreds of millions of dollars and have a better drug find it hard and most fail. The largest of big Pharma blow through hundreds of millions of dollars the first 12 to 24 months, and they already have a sales force.

What type of creative marketing will gain the trust of doctors? If Paragon is able to white label to major retailers that will certainly increase sales. A Lifescan deal would be a gamechanger. I forgot the Door 1-3 details discussed before, but a buyout would be terrific. I am trying to find out if the Johnson and Johnson salespeople still represent Lifescan as far as visiting physicians. That would obviously be important. Perhaps the resident cheerleader might know the structure of Lifescan's sales force moving forward. You can have the best devices in the world, but if doctors don't know about it will it matter?

Read More: https://investorshangout.com/post/view?id=540...z5kWAkpYtk

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Gnosis Lab's Grand Re-Opening: A New Era for Diagnostics

Updated Category News Views 260

Gnosis Lab Grand Re-Opening Celebration Gnosis, a modern diagnostic laboratory previously known as Mountain View Medical Laboratory, is excited to announce its grand re-opening at its flagship location. This event signifies a crucial transition for the lab as it seeks to blend years of reliable community service with a fresh identity and enhanced capabilities. Commitment...

Continue Reading
New Propane Contract Boosts Titan NRG (TTNN) Growth

Updated Category Stocks Views 404

Titan NRG, Inc. Announces Major Propane Contract Secured Titan NRG, Inc. (OTC: TTNN) has a big contract for the 150,000 gallons of propane supply. Given to one of its subsidiaries, this contract represents a significant turning point for the business. Under this contract, propane will be delivered over the next year to a southern Arizona reservation. Crucially in securing...

Continue Reading
Bitcoin Price Decline: Impact of DOJ and Economic Conditions

Updated Category News Views 259

Bitcoin Price Experiences a Notable Decline Bitcoin has recently faced a serious downturn, falling to around $93,925 as fears surrounding U.S. interest rate changes and potential government sales of Bitcoin emerged. This has created a concerning environment for cryptocurrency investors, highlighting the volatility of digital assets. Market Sentiment and Economic Shifts...

Continue Reading
Cogitate and One Inc Team Up to Revolutionize Payments

Updated Category News Views 169

Cogitate Partners with One Inc to Transform Digital Payments -Customers Enjoy a Seamless Experience by Unifying All Payment Flows into One Comprehensive Platform- Cogitate, a provider of cloud-native core policy, billing, and claims applications for insurers, is excited to announce its partnership with One Inc, the leading digital payments network specifically for the...

Continue Reading
Alnylam Pharmaceuticals Achieves New Stock Milestone of $287.88

Updated Category News Views 74

Alnylam Pharmaceuticals Reaches Record Stock Price Alnylam Pharmaceuticals Inc. has recently made headlines after its stock price reached a remarkable all-time high of $287.88. This surge demonstrates a substantial increase in investor confidence, bolstered by an impressive 1-year change of 71.84% in the company's stock. Known for its groundbreaking work in RNA...

Continue Reading